Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogen patient package insert: medication acceptance despite negative attitudes

M Weintraub, S Glickstein, L Lasagna

    Clinical Pharmacology and Therapeutics
    |August 1, 1981
    PubMed
    Summary

    Many women fear estrogen despite short-term postpartum use. Patient package inserts (PPIs) cause anxiety; tailored information is needed for safe, effective medication communication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Post-thrombotic syndrome after central venous catheter removal in childhood cancer survivors: A prospective cohort study.

    Pediatric blood & cancer·2014
    Same author

    Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A.

    Leukemia·2013
    Same author

    Controlled trials: nuisance or necessity?

    Methods of information in medicine·2011
    Same author

    P53 mutations in egyptian bladder-cancer.

    International journal of oncology·2011
    Same author

    Successful second haploidentical SCT in osteopetrosis.

    Bone marrow transplantation·2010
    Same author

    Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.

    Cancer·2010

    Area of Science:

    • Reproductive Medicine
    • Pharmacology
    • Patient Education

    Background:

    • Postpartum lactation suppression often involves short courses of estrogen.
    • Patient Package Inserts (PPIs) provide medication information but may cause unintended anxiety.
    • Understanding patient concerns is crucial for effective health communication.

    Purpose of the Study:

    • To investigate apprehension and attitudes towards short-course postpartum estrogen therapy among women.
    • To identify the impact of the current estrogen Patient Package Insert (PPI) on patient concerns.
    • To recommend improvements in patient information for short-term estrogen use.

    Main Methods:

    • Survey of 100 women receiving short-term postpartum estrogen for lactation suppression.

    Related Experiment Videos

  • Analysis of demographic data, apprehension levels, and reasons for medication use.
  • Assessment of attitudes towards estrogen based on PPI information.

    • Main Results:

    • 36% of women surveyed expressed significant apprehension about estrogen, despite taking it.
    • Apprehensive women were older, better educated, and more likely to be married.
    • Concerns about cancer and thromboembolism, detailed in the PPI, were major drivers of apprehension.

    Conclusions:

    • Current estrogen PPIs, designed for long-term use, generate undue anxiety in women receiving short courses.
    • Healthcare providers should consider tailored PPIs that accurately reflect risks for specific indications.
    • Improved patient education materials are necessary to address medication-related fears and enhance therapeutic adherence.